FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

405963003: Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking) (finding)


Status: current, Primitive. Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2154025016 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50% debulking) en Synonym Active Initial character case insensitive SNOMED CT core
2155048016 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50% debulking) en Synonym Active Initial character case insensitive SNOMED CT core
4434421000168114 Intergroup rhabdomyosarcoma study postoperative clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50% debulking) en Synonym Active Initial character case insensitive SNOMED Clinical Terms Australian extension
4578329013 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking) (finding) en Fully specified name Active Initial character case insensitive SNOMED CT core
4578330015 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking) en Synonym Active Initial character case insensitive SNOMED CT core
4578331016 Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50 percent debulking) en Synonym Active Initial character case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Intergroup rhabdomyosarcoma study postoperative clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50% debulking) Is a Intergroup rhabdomyosarcoma study postoperative clinical group finding true Inferred relationship Some
Intergroup rhabdomyosarcoma study postoperative clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50% debulking) Associated morphology Morphologically abnormal structure false Inferred relationship Some
Intergroup rhabdomyosarcoma study postoperative clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50% debulking) Associated morphology Lesion true Inferred relationship Some 1
Intergroup rhabdomyosarcoma study postoperative clinical group IIIB: Localised or locally extensive tumour, gross residual disease after major resection (greater than 50% debulking) Interprets Lesion observable true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Clinical finding foundation reference set

Problem/Diagnosis reference set

Back to Start